Medicine guide
AREXVY
As listed in the register: AREXVY, poudre et suspension pour suspension injectable. Vaccin du Virus Respiratoire Syncytial (VRS) (recombinant, avec adjuvant)
120 microgrammes · poudre et suspension pour suspension injectable
- Prescription only
- Active substance
- Glycoprotéine F Recombinante Du Virus Respiratoire Syncytial Stabilisée En Forme Pré-Fusion
- Made by
- GLAXOSMITHKLINE BIOLOGICALS
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Details
| Made by | GLAXOSMITHKLINE BIOLOGICALS |
|---|---|
| Active substance | Glycoprotéine F Recombinante Du Virus Respiratoire Syncytial Stabilisée En Forme Pré-Fusion |
| Strength | 120 microgrammes |
| Form | poudre et suspension pour suspension injectable |
| Route | intramusculaire |
| Dispensing (as stated by the register) | liste I |
| Marketed | Yes, according to the register |
| Reinforced monitoring | Yes — under reinforced monitoring, according to the register |
| Authorisation procedure | Procédure centralisée |
| EU number | EU/1/23/1740 |
| Name in the register | AREXVY, poudre et suspension pour suspension injectable. Vaccin du Virus Respiratoire Syncytial (VRS) (recombinant, avec adjuvant) |
| Packs | 1 flacon en verre de 120 microgrammes de poudre - 1 flacon en verre de 0,5 ml de suspension |
| CIS | 64431629 |
| CIP13 | 3400930274170 |
Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician
Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).